A new nationwide study from Japan spanning a 14 year study period has revealed an increasing trend of overweight and obesity in patients with the incident end-stage kidney disease (ESKD).
The Endpoints Slack interview: Lux’s Josh Wolfe on AI hype, biotech markets, Twitter and more
We’re trying something new! Welcome to the first Endpoints Slack Interview, where we chat with interesting people in biotech, pharma, venture capital and science about